SM
ACER

Sabby Management’s Acer Therapeutics Inc ACER Stock Holding History

Sabby Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,530
Closed -$10K – 361
2015
Q4 		$10K Buy
+9,530
New +$315K ﹤0.01% 312

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management's ACER Position: Q1 2016 in Review

Sabby Management sold out of Acer Therapeutics Inc (ACER) in Q1 2016, closing a stake of 9,530 shares — an estimated $10K sold.

Sabby Management first reported a position in ACER in Q4 2015 and held it in 1 quarter. The position peaked at $10K in Q4 2015. 14 funds tracked by Wall St. Rank hold ACER as of Q1 2016.

  • Sabby Management reported no remaining Acer Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 9,530 Acer Therapeutics Inc shares in Q1 2016, an estimated $10K.
  • Sabby Management first reported a position in Acer Therapeutics Inc in Q4 2015 and held it in 1 quarter.
  • Sabby Management's Acer Therapeutics Inc position peaked at $10K in Q4 2015.
  • 14 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.